Editorial: Sequential therapy for eradication of helicobacter pylori: A new guiding light or a false dawn

American Journal of Gastroenterology

Volumn 104, Issue 12, 2009, Pages 3081-3083

  Moayyedi, Paul ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROIMIDAZOLE; AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; DRUG EFFICACY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ITALY; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; META-ANALYSIS AS TOPIC; METRONIDAZOLE; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINIDAZOLE;

EID: 72949121483     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.563     Document Type: Review

References (14)

1. Chey WD, Wong BCY. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-1825
2. Malfertheiner P, Megraud F, O ' Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781 (Pubitemid 46854190)
3. Rokkas T, Sechopoulos P, Robotis I et al. Cumulative H. pylori eradication rates in clinical practice by adopting first and second line regimens proposed by the Maastricht III consensus and a third line empirical regimen. Am J Gastroenterol 2009;104:21-25
4. Gatta L, Vakil N, Leandro G et al. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009;104:3069-3079 (the issue).
5. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naïve to treatment. Ann Intern Med 2008;148:923-931
6. Ford AC, Guyatt G, Talley NJ et al. Errors in meta-analyses of pharmacological interventions in irritable bowel syndrome. Am J Gastroenterol (in press).
7. Yuan Y, Hunt RH. Systematic reviews: the good, the bad, and the ugly. Am J Gastroenterol 2009;104:1086-1092
8. Moayyedi P. Sequential regimens for Helicobacter pylori eradication. Lancet 2007;370:1010-1012
9. Vakil N. H. pylori treatment: new wine in old bottles?. Am J Gastroenterol 2009;104:26-30.
10. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-46
11. Fischbach LA, Bravo LE, Zarama GR et al. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country. Helicobacter 2009;14:100-108
12. Sanchez-Delgado J, Calvet X, Bujanda L et al. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol 2008;103:2220-2223
13. Park S, Chun HJ, Kim ES et al. The 10-day sequential therapy for Helicobacter pylori eradication in Korea: less effective than expected. Gastroenterology 2009;136 (Suppl 1): M1053.
14. Talley NJ, Fock KM, Moayyedi P. Gastric cancer consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008;103:510-514